• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AUTOGEN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AUTOGEN; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G179
Device Problems Signal Artifact/Noise (1036); Over-Sensing (1438); Failure to Read Input Signal (1581)
Patient Problem Device Overstimulation of Tissue (1991)
Event Date 04/15/2021
Event Type  malfunction  
Manufacturer Narrative
This device remains implanted, therefore technical analysis cannot be conducted.Without a returned device it is not possible to definitively confirm how the device may have contributed to the complaint incident.As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
It was reported that this patient was hospitalized due to shortness of breath.Interrogation of the cardiac resynchronization therapy defibrillator (crt-d) device, exhibited over-sensed noise on the right ventricular (rv) channel.A technical service (ts) consultant reviewed the available device data and recommended programming to change the sensitivity settings from 0.6 mv to 1.5 mv.Ts advised some of the noise on the rv channel to be myopotentials related, and only appear when the patient is taking a deep breath.There was no pacing inhibition reported, and no out of range measurements reported.Ts recommended lead integrity testing.The device remains implanted.No adverse patient effects were reported.Additional information was received, programming changes were made to decrease the sensitivity to 1.0 mv.Deep breathing tested was completed, and no over sensing occurred.The patient was discharged home with a holter monitor and will follow up in approximately one month.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AUTOGEN
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key12112247
MDR Text Key260424949
Report Number2124215-2021-10503
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeNZ
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 07/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/25/2016
Device Model NumberG179
Device Catalogue NumberG179
Device Lot Number104511
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/15/2021
Initial Date FDA Received07/02/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/07/2014
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
-
-